Cannabinoid Testing
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Drug Enforcement Administration (DEA) is soliciting proposals for Cannabinoid Testing to evaluate the abuse potential of synthetic and phytocannabinoids using in vivo pharmacological studies. This unrestricted Request for Quote (RFQ) will result in a Firm-Fixed-Price Blanket Purchase Agreement (BPA). Quotes are due by February 9, 2026, at 3:00 PM EST.
Scope of Work
The contractor will conduct preclinical studies, including locomotor activity, cannabinoid tetrad, and drug discrimination studies, on various substances provided by the DEA. These evaluations support the DEA's domestic scheduling activities under the Controlled Substances Act (CSA). Key deliverables include study reports, data presentations, and a final study report for each substance tested. Contractors must possess a Schedule I researcher registration with the DEA and adhere to strict storage requirements for Schedule I substances.
Contract Details
- Type: Firm-Fixed-Price Blanket Purchase Agreement (BPA)
- Duration: Up to 60 months (a base year plus four 12-month option periods).
- Total Not-to-Exceed (NTE): $2.5 million for the entire 60-month period.
- Call Orders: Issued on an as-needed basis; individual call orders cannot exceed $500,000. Multiple call orders can be issued.
- Set-Aside: Unrestricted
- NAICS Code: 541380 (Testing Laboratories and Services) with a $30.5 million size standard.
- Product Service Code (PSC): H966 (Other Quality Control, Testing And Inspection Services: Instruments And Laboratory Equipment). For BPA Terms & Conditions, PSC Q301 (Medical – Laboratory Testing) is relevant.
- Place of Performance: Springfield, VA 22152, United States.
Submission & Evaluation
Quotes must be submitted in two volumes: Volume I (Technical Quote) and Volume II (Business Quote). Evaluation will be based on a "Pass/Fail" for technical requirements and a Lowest-Price-Technically Acceptable (LPTA) approach for the overall award. Key technical evaluation factors include Understanding of the Requirement and Experience/Past Performance. Bidders should refer to pages 4-9 of the solicitation for the schedule of supplies/services and provide a cost breakdown to support their pricing.
Important Clarifications
- Pricing: Bidders must refer to pages 4-9 of the solicitation for the schedule of supplies/services and provide a cost breakdown.
- Period of Performance: The BPA is valid for up to 60 months. Call orders may include all or smaller groups of CLINs, and multiple call orders can be issued within the BPA's duration.
- Budget: Individual call orders are capped at $500,000, with a total NTE of $2.5 million for the 60-month BPA.
Deadlines
- Questions Due: January 22, 2026, by 2:00 PM EST (This date has passed).
- Quotes Due: February 9, 2026, at 3:00 PM EST.